02563

華昊中天醫藥－Ｂ

• PUBT·05/28 14:32

  Beijing Biostar Pharmaceuticals announces annual shareholder meeting

• PUBT·05/28 14:27

  Beijing Biostar Pharmaceuticals announces annual general meeting

• PUBT·05/26 09:34

  Beijing Biostar clarifies employee share option award cap at 1% of issued capital

• PUBT·05/21 12:29

  Beijing Biostar clarifies HK$ 4 subscription price, corrects agreement date to May 6

• PUBT·05/07 14:57

  Beijing Biostar Pharmaceuticals proposes 10-year share option scheme for employee incentives

• PUBT·05/07 14:55

  Beijing Biostar to place 25,000,000 shares at HK$ 4 each for HK$ 100 million

• PUBT·05/07 14:51

  Beijing Biostar Pharmaceuticals plans open-market buyback of up to 10% of H shares

• PUBT·04/28 13:52

  Beijing Biostar Pharmaceuticals files directors list with Hong Kong Stock Exchange

• PUBT·04/28 13:50

  Beijing Biostar proposes Dr. Zhu Xiaodong as independent director after Dr. Meng resigns

• Reuters·03/30 15:07

  Beijing Biostar FY25 net loss narrows 8.6% to RMB 130 million; revenue drops 53.6% to RMB 33 million

• Reuters·03/30 14:43

  Beijing Biostar wins HKEX approval for full circulation of 148 million converted H shares

• Reuters·03/25 14:54

  Beijing Biostar flags expected qualified audit opinion; investment fund recoverability raises accounting concerns

• Reuters·03/25 04:22

  Beijing Biostar shares fall; auditor flags expected qualified opinion on FY2025 results

• Reuters·03/24 13:58

  Beijing Biostar postpones board meeting on annual results approval

• Reuters·02/06 14:45

  Beijing Biostar Pharmaceuticals Receives CSRC Filing Notice for H Share Full Circulation